Phylodynamics of SARS-CoV-2 in France, Europe and the world in 2020

  1. Romain Coppée  Is a corresponding author
  2. François Blanquart
  3. Aude Jary
  4. Valentin Leducq
  5. Valentine Marie Ferré
  6. Anna Maria Franco Yusti
  7. Léna Daniel
  8. Charlotte Charpentier
  9. Samuel Lebourgeois
  10. Karen Zafilaza
  11. Vincent Calvez
  12. Diane Descamps
  13. Anne-Geneviève Marcelin
  14. Benoit Visseaux
  15. Antoine Bridier-Nahmias  Is a corresponding author
  1. Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, France
  2. Collège de France, France
  3. Sorbonne Université, Inserm, iPLESP, France
  4. Hôpital Bichat-Claude-Bernard, France

Abstract

Although France was one of the most affected European countries by the COVID-19 pandemic in 2020, the dynamics of SARS-CoV-2 movement within France, but also involving France in Europe and in the world, remain only partially characterized in this timeframe. Here, we analyzed GISAID deposited sequences from 1st January to 31th December 2020 (n = 638,706 sequences at the time of writing). To tackle the challenging number of sequences without the bias of analyzing a single subsample of sequences, we produced 100 subsamples of sequences and related phylogenetic trees from the whole dataset for different geographic scales (worldwide, European countries and French administrative regions) and time periods (from 1st January to 25th July 2020, and from 26th July to 31th December 2020). We applied a maximum likelihood discrete trait phylogeographic method to date exchange events (i.e., a transition from one location to another one), to estimate the geographic spread of SARS-CoV-2 transmissions and lineages into, from and within France, Europe and the world. The results unraveled two different patterns of exchange events between the first and second half of 2020. Throughout the year, Europe was systematically associated with most of the intercontinental exchanges. SARS-CoV-2 was mainly introduced into France from North America and Europe (mostly by Italy, Spain, United Kingdom, Belgium and Germany) during the first European epidemic wave. During the second wave, exchange events were limited to neighboring countries without strong intercontinental movement, but Russia widely exported the virus into Europe during the summer of 2020. France mostly exported B.1 and B.1.160 lineages, respectively during the first and second European epidemic waves. At the level of French administrative regions, the Paris area was the main exporter during the first wave. But, for the second epidemic wave, it equally contributed to virus spread with Lyon area, the second most populated urban area after Paris in France. The main circulating lineages were similarly distributed among the French regions. To conclude, by enabling the inclusion of tens of thousands of viral sequences, this original phylodynamic method enabled us to robustly describe SARS-CoV-2 geographic spread through France, Europe and worldwide in 2020.

Data availability

All genome sequences and associated metadata in the dataset are published in GISAID's EpiCoV database. To view the contributors of each individual sequence with details such as accession number, virus name, collection date, originating lab and submitting lab and the list of authors, visit: https://doi.org/10.55876/gis8.230120zd.All the scripts developed for this study were deposited in the following GitHub repository: https://github.com/Rcoppee/PhyloCoV

Article and author information

Author details

  1. Romain Coppée

    Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France
    For correspondence
    romain.coppee@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3024-5928
  2. François Blanquart

    Centre for Interdisciplinary Research in Biology, Collège de France, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0591-2466
  3. Aude Jary

    Sorbonne Université, Inserm, iPLESP, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Valentin Leducq

    Sorbonne Université, Inserm, iPLESP, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Valentine Marie Ferré

    Service de Virologie, Hôpital Bichat-Claude-Bernard, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Anna Maria Franco Yusti

    Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Léna Daniel

    Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Charlotte Charpentier

    Service de Virologie, Hôpital Bichat-Claude-Bernard, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Samuel Lebourgeois

    Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Karen Zafilaza

    Sorbonne Université, Inserm, iPLESP, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Vincent Calvez

    Sorbonne Université, Inserm, iPLESP, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Diane Descamps

    Service de Virologie, Hôpital Bichat-Claude-Bernard, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Anne-Geneviève Marcelin

    Sorbonne Université, Inserm, iPLESP, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Benoit Visseaux

    Service de Virologie, Hôpital Bichat-Claude-Bernard, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  15. Antoine Bridier-Nahmias

    Université Paris Cité and Sorbonne Paris Nord, Inserm, IAME, Paris, France
    For correspondence
    antoine.bridier-nahmias@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0376-6840

Funding

No external funding was received for this work.

Copyright

© 2023, Coppée et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 841
    views
  • 118
    downloads
  • 4
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Romain Coppée
  2. François Blanquart
  3. Aude Jary
  4. Valentin Leducq
  5. Valentine Marie Ferré
  6. Anna Maria Franco Yusti
  7. Léna Daniel
  8. Charlotte Charpentier
  9. Samuel Lebourgeois
  10. Karen Zafilaza
  11. Vincent Calvez
  12. Diane Descamps
  13. Anne-Geneviève Marcelin
  14. Benoit Visseaux
  15. Antoine Bridier-Nahmias
(2023)
Phylodynamics of SARS-CoV-2 in France, Europe and the world in 2020
eLife 12:e82538.
https://doi.org/10.7554/eLife.82538

Share this article

https://doi.org/10.7554/eLife.82538

Further reading

    1. Epidemiology and Global Health
    Marina Padilha, Victor Nahuel Keller ... Gilberto Kac
    Research Article Updated

    Background:

    The role of circulating metabolites on child development is understudied. We investigated associations between children’s serum metabolome and early childhood development (ECD).

    Methods:

    Untargeted metabolomics was performed on serum samples of 5004 children aged 6–59 months, a subset of participants from the Brazilian National Survey on Child Nutrition (ENANI-2019). ECD was assessed using the Survey of Well-being of Young Children’s milestones questionnaire. The graded response model was used to estimate developmental age. Developmental quotient (DQ) was calculated as the developmental age divided by chronological age. Partial least square regression selected metabolites with a variable importance projection ≥1. The interaction between significant metabolites and the child’s age was tested.

    Results:

    Twenty-eight top-ranked metabolites were included in linear regression models adjusted for the child’s nutritional status, diet quality, and infant age. Cresol sulfate (β=–0.07; adjusted-p <0.001), hippuric acid (β=–0.06; adjusted-p <0.001), phenylacetylglutamine (β=–0.06; adjusted-p <0.001), and trimethylamine-N-oxide (β=–0.05; adjusted-p=0.002) showed inverse associations with DQ. We observed opposite directions in the association of DQ for creatinine (for children aged –1 SD: β=–0.05; pP=0.01;+1 SD: β=0.05; p=0.02) and methylhistidine (–1 SD: β = - 0.04; p=0.04;+1 SD: β=0.04; p=0.03).

    Conclusions:

    Serum biomarkers, including dietary and microbial-derived metabolites involved in the gut-brain axis, may potentially be used to track children at risk for developmental delays.

    Funding:

    Supported by the Brazilian Ministry of Health and the Brazilian National Research Council.

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Gillian AM Tarr, Linda Chui ... Tim A McAllister
    Research Article

    Several areas of the world suffer a notably high incidence of Shiga toxin-producing Escherichia coli. To assess the impact of persistent cross-species transmission systems on the epidemiology of E. coli O157:H7 in Alberta, Canada, we sequenced and assembled E. coli O157:H7 isolates originating from collocated cattle and human populations, 2007–2015. We constructed a timed phylogeny using BEAST2 using a structured coalescent model. We then extended the tree with human isolates through 2019 to assess the long-term disease impact of locally persistent lineages. During 2007–2015, we estimated that 88.5% of human lineages arose from cattle lineages. We identified 11 persistent lineages local to Alberta, which were associated with 38.0% (95% CI 29.3%, 47.3%) of human isolates. During the later period, six locally persistent lineages continued to be associated with human illness, including 74.7% (95% CI 68.3%, 80.3%) of reported cases in 2018 and 2019. Our study identified multiple locally evolving lineages transmitted between cattle and humans persistently associated with E. coli O157:H7 illnesses for up to 13 y. Locally persistent lineages may be a principal cause of the high incidence of E. coli O157:H7 in locations such as Alberta and provide opportunities for focused control efforts.